Jeff Aronin, a Managing Director at Paragon Biosciences, contributes to a global life science leader that actively creates, builds. See contact routes.
Jeff Aronin, a Managing Director at Paragon Biosciences, contributes to a global life science leader that actively creates, builds, and funds innovative biology-based companies. His work at the Chicago-based venture capital firm focuses on accelerating life science innovation. Paragon Biosciences strategically supports companies developing therapies for critical areas, including neurological disorders, rare diseases, severe skin and connective tissue disorders, and regenerative medicines. A key aspect of their approach involves leveraging generative AI, particularly for the development of advanced protein therapeutics. This focus underscores a commitment to pioneering solutions in complex biological and medical fields.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Chicago when building a target list.
Investors like Jeff Aronin · Full investor directory · Investor access · Company funding database